Abeona Therapeutics (AKC) Q1 2026 Earnings

17MarConfirmed
Q1 2025
Q3 2025
Q4 2025
Q1 2026
-0.39
0.31
1.01
1.71

Details

Expected EPS
-0.352
Actual EPS
-0.36
Surprise EPS
-0.01
Surprise Percent
+2.27%

Description

Abeona Therapeutics (AKC) has reported earnings of -0.36 per share for Q1 2026.

0 Comments

Share your thoughts